Clinical Trials Browser

Suspended × OTHER × Adjuvants, Immunologic × Clear all

NCT06130826 2026-06-03

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Phase 1 Suspended

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms